Viewing StudyNCT00385255



Ignite Creation Date: 2024-05-05 @ 5:05 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00385255
Status: COMPLETED
Last Update Posted: 2019-06-10
First Post: 2006-10-06

Brief Title: Immunogenicity Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Tetanus
Acellular Pertussis
Diphtheria
Keywords:
Name View
Tdap View
Immunogenicity View
Influenza View
Co-administration View